Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

A Retrospective Cohort Study of Hospitalised Patients With First-Episode Substance-Induced Psychosis and First-Episode Psychosis: Comparing Long-Acting Injectable Antipsychotic Use and Post-Discharge Outcomes

AI Summary
  • LAI antipsychotics were far less often administered or recommended for FESIP than FEP (administered 1.2% vs 11.1%; recommended 1.2% vs 33.3%).
  • Rehospitalisation and emergency department encounter rates after discharge were similar for FEP and FESIP, with no difference in time to first events.
  • Findings indicate clinical uncertainty in LAI-AP treatment for substance-induced psychosis and underscore need for research to guide early intervention strategies.
Summarise with AI (MRCPsych/FRANZCP)

Early Interv Psychiatry. 2026 Sep;20(9):e70250. doi: 10.1111/eip.70250.

ABSTRACT

INTRODUCTION: Clinicians may not recommend long-acting injectable antipsychotics (LAI-APs) for patients diagnosed with first-episode substance-induced psychosis (FESIP), despite the risk of transition from FESIP to schizophrenia and the effectiveness of LAI-AP in early psychosis. We compared LAI-AP use and post-discharge outcomes between patients with first-episode psychosis (FEP) and those with FESIP during their index psychiatric hospitalisation.

METHODS: We conducted a retrospective cohort study using electronic health record data from patients aged 18-39 who were discharged from inpatient psychiatry units at a public academic hospital between 2021 and 2024. Outcomes included administration of any LAI-AP during the index hospitalisation, documented recommendation of any LAI-AP, psychiatric rehospitalisation and emergency department (ED) encounters after discharge.

RESULTS: The cohort included 90 patients with FEP and 84 patients with FESIP. Only one (1.2%) patient with FESIP received an LAI-AP compared with 10 (11.1%) with FEP (OR = 0.10, 95% CI = 0.002-0.71); LAI-AP was recommended to one (1.2%) patient with FESIP compared with 30 (33.3%) with FEP (OR = 0.02, 95% CI = 0.0006-0.16). Rehospitalisation occurred in 41 (45.6%) patients with FEP and 38 (45.2%) with FESIP; post-discharge ED encounters occurred in 50 (55.6%) and 52 (61.9%) patients, respectively. Time to first rehospitalisation and ED encounter after discharge did not differ between the groups.

CONCLUSIONS: Despite similar post-discharge outcomes between patients with FEP and FESIP, administration or recommendation of an LAI-AP was rarer among those with FESIP. Our findings highlight uncertainty in treatment decision-making and support further research to guide early intervention strategies in patients with substance-induced psychosis.

PMID:42765189 | DOI:10.1111/eip.70250

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD